Metabolic surgery may help reduce heart failure-related risk factors

Pennington Biomedical Research Center researchers at the Metamor Institute, along with colleagues from Our Lady of the Lake and LSU Health-New Orleans, have recently determined that metabolic surgery on patients with heart failure can result in a reduction in the need for oral diuretics, which are used to manage symptoms such as venous and vascular pressures.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup